An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors
Status:
Recruiting
Trial end date:
2023-07-10
Target enrollment:
Participant gender:
Summary
This trial studies how well an investigational scan called 68Ga-DOTATATE PET/CT works in
diagnosing pediatric patients with neuroendocrine tumors that have spread to other places in
the body (metastatic). A neuroendocrine tumor is an abnormal growth of neuroendocrine cells,
which are cells resembling nerve cells and hormone-producing cells. 68Ga-DOTATATE is a
radioactive substance called a radiotracer that when used with PET/CT scans, may work better
than standard of care MIBG scans in diagnosing pediatric metastatic neuroendocrine tumors and
targeting them with radiation therapy.